COVID-19 has ignited biotech and digital health investment activity – from telemedicine to drug trial technology to precision genomics. In 2020, biotech IPO’s continued to pique investor interest and venture capital fundraising in healthcare reached record levels- and 2021 shows no sign of abating. According to Crunchbase, there has been $4.1B+ in health-related investment deals this year to date.
While the pandemic has accelerated new innovations that are disrupting healthcare, the pace of change will continue well into the future.
Join our panelists for a dynamic discussion on the emerging technologies that are changing healthcare as we know it, reflect on this past year’s funding trends, and where investors will be placing their bets in the future.
This series is powered by Frank, Rimerman + Co. LLP, certified public accountants!
If you have any questions about this event please email firstname.lastname@example.org.